Fundraising FoxPBM Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
BiotechMorrisville, US
Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in
BoardStephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)
Board seatPaul B. Manning· per SEC Form D · $21.7M raise · filed Apr 2021
Co-investorsCanaan PartnersNew Enterprise Associates (NEA)Xeraya Capital
BiotechCharlottesville, US
Raymond Chavez(Executive Officer, Director)inStephen Collins(Executive Officer, Director)inLinda Watkins(Director)
BoardPeter Heinecke(Director)John Forsayeth(Director)
Board seatPaul B. ManningJayson Rieger· per SEC Form D · $30M raise · filed Jun 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.